Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2024–2027 · research · R21
Impact of tamoxifen treatment on neutrophils in breast cancer patients
Jyotika Sharma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R35
Development of large-scale composite null hypothesis testing approaches to perform translational genetics analyses
Ryan Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2028 · research · R01
Angiotensin Signaling Underlies Myeloid and Sensory Disruption in Diabetes
Andrew John Shepherd · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R37
Mechanisms of Hyperprogression to Immunotherapy in SMARCB1-Deficient Renal Malignancies
Pavlos Msaouel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R37
Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers
Lauren Elizabeth Colbert · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs
Paul A Scheet · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2028 · research · R01
Replication fork protection and innate immune response
Bin Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R35
A Functional Analysis of Arginine Methylation
Mark T. Bedford · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2026 · research · R01
Maintenance of genome stability in 3D
Jean Gautier · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2028 · research · R01
Targeting the gut microbiome to inhibit melanoma lymph node metastases
Ashley M Holder · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R25
Supporting Tobacco-Related Ongoing Education and Research (STRONGER) Scholar Program
Lorraine R Reitzel · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · research · R01
Reproductive tract organ development and differentiation
Richard R Behringer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2028 · research · R01
Noncanonical roles of Bim in heat shock-induced cell death
Shawn B Bratton · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · program · P01
Core C: Patient-Reported Outcomes & Function (PROF)
Carly E. A. Barbon · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · program · P01
Project 2: OPC-NERVE
Katherine Arnold Hutcheson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · program · P01
Project 3: OPC-RAD
Steven Jay Frank · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2029 · program · P01
Core A: Administrative
Katherine Arnold Hutcheson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
Ana Aparicio · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Overcoming therapy resistance by integrated computational modeling of the bone metastatic niche in prostate and renal cancers
Eleonora Dondossola · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023 · training · Postgraduate Scholarships - Doctoral
Full Lineal Energy Spectrum Based Tumour and Normal Tissue Biological Effect Models for Ion Therapy
Joseph Jmd Decunha · The University of Texas MD Anderson Cancer Center · funded by Natural Sciences and Engineering Research Council of Canada
2023 · grant · Prevention
Active Living After Cancer: Combining a Physical Activity Program with Survivor Navigation
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023 · grant · Academic Research
Blocking DNA damage response induction of “don’t eat me” signals converts local radiotherapy into systemic immunotherapy
Michael Curran · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2027 · research · R01
Targeting the LIFR-LCN2 pathway to improve liver cancer therapy
Li Ma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
Rugang Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
Roza Insafetdinovna Nurieva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of fasting-induced radioprotection of small intestinal epithelial cells
Helen M Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · award
T cell membrane-anchored tumor targeted Il12 (attIL12)-T cell therapy in subjects with advanced/metastatic sarcoma
John Livingston · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2023 · grant · Prevention
Taking Texas Tobacco Free: Dissemination to and Implementation within Centers Serving Texans who Identify as LGBTQ+
Lorraine Reitzel · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R01
Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer
Natalie Vokes · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Alpha particles combined with ATR inhibition to activate the immune system: mechanisms and pre-clinical translation
Gabriel Oliveira Sawakuchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Geospatial Approaches to Melanoma Early Detection - The GAMED Project
Kelly Nelson · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2025 · research · R21
Hyperpolarized 129Xe MRI for imaging NK cell therapy of lung metastasis
James A Bankson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Lorenzo Cohen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · cooperative agreement · UH3
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
William F Symmans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Next Generation Engineered NK Cells for Lymphoma Patients after CD19 CAR-T Cell Failure.
Rafet Basar · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Spatio-temporal regulation of ERK signaling by phosphatases in the female germline
Swathi Arur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Prevention
Taking Texas Tobacco Free: Dissemination to and Implementation within Lung Cancer Screening Programs
Lorraine Reitzel · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2026 · research · R21
Hyperpolarized 129Xe MRI for imaging NK cell therapy of lung metastasis
James A Bankson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
